American heart Association/American college of cardiology Foundation/Heart rhythm society scientific statement on Noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death - A scientific statement from the American heart association council on clinical cardiology committee on electrocardiography and arrhythmias and council on epidemiology and prevention

被引:143
作者
Goldberger, Jeffrey J.
Cain, Michael E.
Hohnloser, Stefan H.
Kadish, Alan H.
Knight, Bradley P.
Lauer, Michael S.
Maron, Barry J.
Page, Richard L.
Passman, Rod S.
Stevenson, William G.
Zipes, Douglas P.
机构
关键词
AHA Scientific Statements; death; sudden; risk assessment;
D O I
10.1016/j.jacc.2008.05.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Given the availability of therapies to prevent SCD due to otherwise fatal ventricular tachyarrhythmias, it is important to differentiate noninvasive risk stratification techniques that enhance the ability to identify SCD from total mortality. The relative ability for each of the described techniques varies, and the optimal way to combine and use these techniques in clinical practice remains unclear. Low LVEF, which is the most widely used test on which ICD intervention is recommended, does not have a particularly high discriminatory ability to identify SCD rather than non-SCD mortality. Although data exist supporting the concept that noninvasive risk stratification techniques may be useful to identify patients with low LVEF who are at low risk for SCD, this requires further testing. There are also data to support the concept that noninvasive risk stratification techniques may be useful to identify patients who do not have low LVEF who nevertheless are at substantial risk for SCD. Because most SCD occurs in this latter group, substantial effort is justified in evaluating, testing, and ultimately implementing risk stratification strategies in this group. © 2008 American Heart Association, Inc, the American College of Cardiology Foundation, and the Heart Rhythm Society.
引用
收藏
页码:1179 / 1199
页数:21
相关论文
共 206 条
  • [21] QT dispersion has no prognostic information for patients with advanced congestive heart failure and reduced left ventricular systolic function
    Brendorp, B
    Elming, H
    Jun, L
    Kober, L
    Malik, M
    Jensen, GB
    Torp-Pedersen, C
    [J]. CIRCULATION, 2001, 103 (06) : 831 - 835
  • [22] A randomized study of the prevention of sudden death in patients with coronary artery disease
    Buxton, AE
    Lee, KL
    Fisher, JD
    Josephson, ME
    Prystowsky, EN
    Hafley, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (25) : 1882 - 1890
  • [23] QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators
    Buxton, AE
    Sweeney, MO
    Wathen, MS
    Josephson, ME
    Otterness, MF
    Hogan-Miller, E
    Stark, AJ
    DeGroot, PJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (02) : 310 - 316
  • [24] Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease - An analysis of patients enrolled in the Multicenter Unsustained Tachycardia Trial
    Buxton, AE
    Lee, KL
    Hafley, GE
    Wyse, DG
    Fisher, JD
    Lehmann, MH
    Pires, LA
    Gold, MR
    Packer, DL
    Josephson, ME
    Prystowsky, EN
    Talajic, MR
    [J]. CIRCULATION, 2002, 106 (19) : 2466 - 2472
  • [25] Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT
    Cairns, JA
    Connolly, SJ
    Roberts, R
    Gent, M
    [J]. LANCET, 1997, 349 (9053) : 675 - 682
  • [26] Camm AJ, 1996, CIRCULATION, V93, P1043
  • [27] Mortality in patients after a recent myocardial infarction - A randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification
    Camm, AJ
    Pratt, CM
    Schwartz, PJ
    Al-Khalidi, HR
    Spyt, MJ
    Holroyde, MJ
    Karam, R
    Sonnenblick, EH
    Brum, JMG
    [J]. CIRCULATION, 2004, 109 (08) : 990 - 996
  • [28] THE VALUE OF CATHETER MAPPING DURING SINUS RHYTHM TO LOCALIZE SITE OF ORIGIN OF VENTRICULAR-TACHYCARDIA
    CASSIDY, DM
    VASSALLO, JA
    BUXTON, AE
    DOHERTY, JU
    MARCHLINSKI, FE
    JOSEPHSON, ME
    [J]. CIRCULATION, 1984, 69 (06) : 1103 - 1110
  • [29] Centers for Medicare and Medicaid Services, NAT COV DET IMPL DEF
  • [30] Heart rate recovery following maximal exercise testing as a predictor of cardiovascular disease and all-cause mortality in men with diabetes
    Cheng, YLJ
    Lauer, MS
    Earnest, CP
    Church, TS
    Kampert, JB
    Gibbons, LW
    Blair, SN
    [J]. DIABETES CARE, 2003, 26 (07) : 2052 - 2057